参考文献/References:
[1] 万雷,黄宏兴.肌少-骨质疏松症的病理机制[J].中医正骨,2026,38(1):1-6.
[2] YI Y T,ZHAO H F,WANG W Z,et al. Osteosarcopenia: epidemiology,molecular mechanisms,and management[J].Front Endocrinol(Lausanne),2025,16:1577758.
[3] 林贤灿,吴建军,杨志杰,等.肌少-骨质疏松症研究现状与展望[J].中国骨质疏松杂志,2023,29(5):676-681.
[4] MOCINI E,PICCIOCCHI C,DEFEUDIS G,et al. Sarcopenia and osteoporosis[J/OL].Gerontology,2025:1-13[2025-10-06]. https://pubmed.ncbi.nlm.nih.gov/40545813/.
[5] 张乃心,徐天舒,王钐,等.女贞子防治肌少-骨质疏松症的中医理论探讨[J].中国中医基础医学杂志,2024,30(10):1747-1750.
[6] 张通海,王礼宁,马勇,等.基于五体理论探讨五体与肌少-骨质疏松症的关系及肌少-骨质疏松症的治疗[J].中医正骨,2024,36(7):51-54.
[7] 金雨静,黄世敬.论甘草在张仲景方药体系中的核心作用[J].北京中医药大学学报,2024,47(7):917-923.
[8] 韩兴稷,焦太强,茆春阳,等.甘守津还法探微[J].中医文献杂志,2025,43(6):38-43.
[9] 余盈晖,刘成丽.基于胃阴学说探析叶天士辨治胃阴虚证经验[J].新中医,2025,57(14):161-165.
[10] 谭国志,林贤灿,黄佳纯,等.基于异病同治理论探讨肌少症与骨质疏松症的治疗原则[J].世界中西医结合杂志,2024,19(6):1260-1264.
[11] 李翼,陈崇利,赵梦洁,等.肌少-骨质疏松症中医病机及防治思路初探[J].甘肃中医药大学学报,2020,37(4):38-41.
[12] 柴勇,赵宏艳,刘红,等.基于脏腑辨证理论探讨骨质疏松症的中医治疗[J].中国中医基础医学杂志,2019,25(3):302-304.
[13] 魏静,魏凯善,罗敏,等.从“脾”论治肌肉减少症[J].中医药临床杂志,2019,31(7):1282-1284.
[14] 宋梧桐,曹洪欣.从“体阴用阳”认识脾病病机与证候特征[J].中华中医药杂志,2023,38(10):4758-4761.
[15] 苗德胜,吕发明,杨新军,等.王继先教授以燥论治骨质疏松症[J].中医正骨,2022,34(9):73-75.
[16] 任爽,刘妍彤,张杰.基于“脾气热”理论探讨类风湿肌少症的治疗及其效应机制[J].中华中医药学刊,2022,40(10):40-43.
[17] 吴亚东,郭振光,邓文杰,等.基于“脾主肌肉”探讨补中益气汤对骨质疏松椎体压缩性骨折术后临床疗效及骨转换标志物的影响[J].中国实验方剂学杂志,2022,28(17):91-97.
[18] 赵仲雪,刘创,袁佺,等.基于“甘守津还”理论探析慢性阻塞性肺疾病合并肌少症中医病机与治疗思路[J].辽宁中医药大学学报,2025,27(6):59-62.
[19] 杨青峰,蒋宜伟,于继凯,等.黄芪桂枝五物汤在骨伤科的临床应用[J].中医药临床杂志,2020,32(12):2381-2384.
[20] 王晓仪,王海郦,刘雨彤,等.健脾利湿药治疗骨质疏松症的脂代谢调控相关机制探讨[J].中国骨质疏松杂志,2023,29(12):1819-1825.
[21] 毛国庆,陈世洲.三甲复脉汤治疗阴虚质骨质疏松症经验[J].中国中医药信息杂志,2019,26(11):115-117.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):16.
[11]李嘉彤,李念虎.基于“脾肾-营卫-络脉”理论论治肌少-骨质疏松症[J].中医正骨,2024,36(03):74.
[12]万雷,黄宏兴.肌少-骨质疏松症的病理机制[J].中医正骨,2026,38(01):1.